6,139
Views
128
CrossRef citations to date
0
Altmetric
Current Clinical Practice

Hyposplenism: A comprehensive review. Part I: Basic concepts and causes

&
Pages 1-13 | Published online: 04 Sep 2013

References

  • Doll DC, List AF, Yarbro JW. Functional hyposplenism. South Med J 1987;80:999–1006.
  • Erslev AJ. Hypersplenism and hyposplenism. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, editors. Williams hematology. New York, NY: McGraw-Hill; 2001. p 683–687.
  • Eppinger H. Zur pathologie der milzfunktion. Klin Wochenschr 1913;50:1509–1512.
  • Dameshek W. Hypersplenism. Bull NY Acad Sci 1955; 31:113.
  • Schilling V. Uber die diagnose einer milzatrophie durch den befiind von kernkugelin als teilersche teilerscheiung plur-iglandularer insuffzienz. Klin Wochenschr 1924;43: 1960–1962.
  • Dameshek W. Hyposplenism (Letter). JAMA 1955;157:163.
  • Chen LT. Microcirculation of the spleen: And open or closed circulation? Science 1978;201:157–159.
  • Weiss L. A scanning electron microscopic study of the spleen. Blood 1974;43:665–691.
  • Schulkind ML, Ellis EF, Smith RT. Effect of antibody upon clearance of I-125-labelled pneumococci by the spleen and liver. Pediatr Res 1967;1: 178–184.
  • Rowley DA. The formation of circulating antibody in the splenectomized human being following intravenous injection of heterologous erythrocytes. J Immunol 1950;65:515.
  • Lildiite VV. Immunological impairment and susceptibility to infection after splenectomy. JAMA 1976;236:1376–1377.
  • Eichner ER. Splenic function: Normal, too much and too little. Am J Med 1979;66:311–320.
  • Constantopoulos A, Najjar VA, Wish JB, Necheles TH, Stolbach LL. Defective phagocytosis due to tuftsin deficiency in splenectomized subjects. Am J Dis Child 1973;125: 663–665.
  • Spirer Z, Zakuth V, Diamant S, Mondorf W, Stefanescu T, Stabinsky Y, et al. Decreased tuftsin concentrations in patients who have undergone splenectomy. Br Med J 1977;2: 1574–1576.
  • Constantopoulos A, Likhite V, Crosby WIT, Najjar VA. Phagocytic activity of the leukemic cell and its response to the phagocytosis-stimulating tetrapeptide, tuftsin. Cancer Res 1973;33:1230–1234.
  • Spirer Z, Zakuth V, Diamant S, Mondorf W, Stefanescu T, Stabinsky Y, et al. Decreased tuftsin concentrations in patients who have undergone splenectomy. Br Med J 1977;2: 1574–1576.
  • Spirer Z, Weisman Y, Zakuth V, Fridkin M, Bogair N. Decreased serum tuftsin concentrations in sickle cell disease. Arch Dis Child 1980;55:566–567.
  • Corazza GR, Zoli G, Ginaldi L, Cancellieri C, Profeta V, Gasbarrini G, et al. Tuftsin deficiency in AIDS. Lancet 1991;337:12–13.
  • Corazza GR, Zoli G, Di Sabatino A, Ciccocioppo R, Gasbarrini G. A reassessment of splenic hypofunction in celiac disease. Am J Gastroenterol 1999;94:391–397.
  • Trevisani F, Castelli E, Foschi FG, Parazza M, Loggi E, Bertelli M, et al. Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome. Gut 2002;50:707–712.
  • Kruetzmann S, Rosado MM, Weber H, Germing U, Tournilhac O, Peter HH, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infec-tions are generated in the spleen. J Exp Med 2003;197: 939–945.
  • Forster I, Rajewsky K. Expansion and functional activity of Ly-1 + B cells upon transfer of peritoneal cells into allotype-congenic, newborn mice. Eur J Immunol 1987;17:521–528.
  • Wardemann H, Boehm T, Dear N, Carsetti R. B-la B cells that link the innate and adaptive immune responses are lacking in the absence of the spleen. J Exp Med 2002; 195:771–780.
  • Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M + IgD + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998;188: 1679–1689.
  • Liu YJ, Malisan F, de Bouteiller O, Guret C, Lebecque S, Banchereau J, et al. Within germinal centers, isotype switching of immunoglobulin genes occurs after the onset of somatic mutation. Immunity 1996;4:241–250.
  • Klein U, Rajewsky K, Kuppers R. Human immunoglobulin (Ig)M + IgD + peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med 1998;188: 1679–1689.
  • Kruetzmann 5, Rosado MM, Weber H, Germing U, Tournilhac O, Peter HH, et al. Human immunoglobulin M memory B cells controlling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003;197:939–945.
  • Eichner ER. Splenic function: Normal, too much and too little. Am J Med 1979;66:311–320.
  • McBride JA, Dacie JV, Shapley R. The effect of splenectomy on the leucocyte count. Br J Haematol 1968;14:225–231.
  • Spencer RP, Pearson HA, Binder HJ. Identification of cases of "acquired" functional asplenia. J Nucl Med 1970;11: 763–766.
  • Pearson HA, Spencer RP, Cornelius EA. Functional asplenia in sickle-cell anemia. N Engl J Med 1969;281:923–926.
  • Steinberg MH, Gatling RR, Tavassoli M. Evidence of hyposplenism in the presence of splenomegaly. Scand J Haematol 1983;31:437–439.
  • Muller AF, Toghill PJ. Splenic function in alcoholic liver disease. Gut 1992;33:1386–1389.
  • Stockman JA, III, Oski FA. Erythrocytes of the human neonate. Curr Top Hematol 1978;1:193–232.
  • Holroyde CP, Oski FA, Gardner FH. The "pocked" erythrocyte. Red-cell surface alterations in reticuloendothe-lial immaturity of the neonate. N Engl J Med 1969;281: 516–520.
  • Rose V, Izukawa T, Moes CA. Syndromes of asplenia and polysplenia. A review of cardiac and non-cardiac malfor-mations in 60 cases withspecial reference to diagnosis and prognosis. Br Heart J 1975;37: 840–852.
  • Ivemark B. Implications of agenesis of the spleen on the pathogenesis of cono-truncus anomalies in childhood. Acta Paediatr 1955;44:1–110.
  • Rose V, Izukawa T, Moes CA. Syndromes of asplenia and polysplenia. A review of cardiac and non-cardiac malfor-mations in 60 cases with special reference to diagnosis and prognosis. Br Heart J 1975;37: 840–852.
  • Britz-Cunningham SH, Shah MM, Zuppan CW, Fletcher WIT. Mutations of the Connexin43 gap-junction gene in patients with heart malformations and defects of laterality. N Engl J Med 1995;332: 1323–1329.
  • Pearson HA, Schiebler GL, Spencer RP. Functional hyposplenia in cyanotic congenital heart disease. Pediatrics 1971;48:277–280.
  • Bjorses P, Pelto-Huikko M, Kaukonen J, Aaltonen J, Peltonen L, Ulmanen I. Localization of the APECED protein in distinct nuclear structures. Hum Mol Genet 1999;8: 259–266.
  • Bjorses P, Aaltonen J, Horelli-Kuitunen N, Yaspo ML, Peltonen L. Gene defect behind APECED: A new clue to autoimmunity. Hum Mol Genet 1998;7:1547–1553.
  • Starzyk J, Kumorowicz-Kopiec M, Kowalczyk M, Starzyk B, Rybakowa M, Dziatkowiak H. Natural history of asplenism in APECED-patient report. J Pediatr Endocrinol Metab 2001;14:443–449.
  • Stormorken H. Stormorken’s syndrome. Tidsskr Nor Laegeforen 2002;122:2853–2856.
  • Alvarez O, Miller JH, Coates TD. Thrombocytosis and hyposplenism in an infant with fetal hydantoin syndrome. Am J Pediatr Hematol Oncol 1992;14:62–65.
  • Freeman SB, Muralidharan K, Pettay D, Blackston RID, May KM. Asplenia syndrome in a child with a balanced reciprocal translocation of chromosomes 11 and 20 [46,XX, t(11;20)(q13.1;q13.13)]. Am J Med Genet 1996;61: 340–344.
  • Robinson RG, Adler R, Swanson VL, Williams KO, Siegel SE. Congenital hypoplastic anemia (CHA) associated with congenital absence of the spleen. Am J Pediatr Hematol Oncol 1982;4:341–344.
  • Diggs LW. Siderofibrsosis of the spleen in sickle cell anemia. JAMA 1935;104:538–541.
  • Jenkins ME, Scott RB, Baird RL. Studies in sickle cell anemia. XVI Sudden death during sickle cell anemia crisis in young children. J Pediat 1960;56:30–38.
  • Pearson HA, Spencer RP, Cornelius EA. Functional asplenia in sickle-cell anemia. N Engl J Med 1969;281:923–926.
  • Pearson HA, Spencer RP, Cornelius EA. Functional asplenia in sickle-cell anemia. N Engl J Med 1969;281:923–926.
  • Pearson HA, McIntosh S, Ritchey AK, Lobel JS, Rooks Y, Johnston D. Developmental aspects of splenic function in sickle cell diseases. Blood 1979;53:358–365.
  • Wali YA, Al Lamki Z, Hussein SS, Bererhi H, Kumar D, Wasifuddin S, et al. Splenic function in Omani children with sickle cell disease: Correlation with severity index, hemo-globin phenotype, iron status, and alpha-thalassemia trait. Pediatr Hematol Oncol 2002;19:491–500.
  • Mallouh A, Burke GM, Salamah M, Ahmad MS. Splenic function in Saudi children with sickle cell disease. Ann Trop Paediatr 1984;4:87–91.
  • Mallouh A, Burke GM, Salamah M, Ahmad MS. Splenic function in Saudi children with sickle cell disease. Ann Trop Paediatr 1984;4:87–91.
  • el Mouzan MI, al Awamy BH, al Torki MT, Niazi GA. Variability of sickle cell disease in the eastern province of Saudi Arabia. J Pediatr 1989;114:973–976.
  • Al Awamy B, Wilson WA, Pearson HA. Splenic function in sickle cell disease in the eastern province of Saudi Arabia. J Pediatr 1984;104:714–717.
  • Adelcile AD, McKie KM, Adeodu 00, Sulzer AJ, Liu JS, McKie VC, et al. Spleen in sickle cell anemia: Comparative studies of Nigerian and U.S. patients. Am J Hematol 1993; 42:316–321.
  • Pearson HA, Spencer RP, Cornelius EA. Functional asplenia in sickle-cell anemia. N Engl J Med 1969;281:923–926.
  • Gill FM, Sleeper LA, Weiner SJ, Brown AK, Bellevue R, Grover R, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. Cooperative study of sickle cell disease. Blood 1995;86:776–783.
  • Garnett ES, Goddard BA, Markby D, Webber CE. The spleen as an arteriovenous shunt. Lancet 1969;1:386–388.
  • Pearson HA, Spencer RP, Cornelius EA. Functional asplenia in sickle-cell anemia. N Engl J Med 1969;281:923–926.
  • Spirer Z, Weisman Y, Zakuth V, Fridkin M, Bogair N. Decreased serum tuftsin concentrations in sickle cell disease. Arch Dis Child 1980;55:566–567.
  • Raghupathy R, Haider MZ, Azizieh F, Abdelsalam R, D’Souza TM, Adelcile AD. Thl and ’Th2 cytokine profiles in sickle cell disease. Acta Haematol 2000;103: 197–202.
  • Pearson HA, Cornelius EA, Schwartz AD, Zelson JH, Wolfson SL, Spencer RP. Transfusion-reversible functional asplenia in young children with sickle-cell anemia. N Engl J Med 1970;283:334–337.
  • Barrios NJ, Livaudais F, McNeil J, Humbert JR, Corrigan J. Reversible splenic hypofunction in hypertransfused children with homozygous sickle cell disease. J Natl Med Assoc 1993;85:677–680.
  • Pearson HA, Cornelius EA, Schwartz AD, Zelson JH, Wolfson SL, Spencer RP. Transfusion-reversible functional asplenia in young children with sickle-cell anemia. N Engl J Med 1970;283:334–337.
  • Campbell PJ, Olatunji PO, Ryan KE, Davies SC. Splenic regrowth in sickle cell anaemia following hypertransfusion. Br J Haematol 1997;96:77–79.
  • Ferster A, Bujan W, Corazza F, Devalck C, Fondu P, Tappet M, et al. Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia. Blood 1993;81:1102–1105.
  • Santos A, Pinheiro V, Anjos C, Brandalise S, Fahel F, Lima M, et al. Scintigraphic follow-up of the effects of therapy with hydroxyurea on splenic function in patients with sickle cell disease. Eur J Nucl Med Mol Imaging 2002;29:536–541.
  • Wang WC, Wynn LW, Rogers ZR, Scott JP, Lane PA, Ware RE. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia. J Pediatr 2001;139: 790–796.
  • Foster PN, Losowsky MS. Hyposplenism-a review. J R Coll Physicians Lond 1987;21:188–191.
  • McCarthy CF, Fraser ID, Evans KT, Read AE. Lymphor-eticular dysfunction in idiopathic steatorrhoea. Gut 1966; 7:140–148.
  • Marsh GW, Stewart JS. Splenic function in adult coeliac disease. Br J Haematol 1970;19:445–457.
  • Corazza GR, Lazzari R, Frisoni M, Collina A, Gasbarrini G. Splenic function in childhood coeliac disease. Gut 1982; 23:415–416.
  • Foster PN, Losowsky MS. Hyposplenism-a review. J R Coll Physicians Lond 1987;21:188–191.
  • Fish JC, Beathard G, Sarles HE, Remmers AR, Jr, Ritzmann SE. Circulating lymphocyte depletion: Effect on lymphoid tissue. Surgery 1970;67:658–666.
  • Palmer KR, Barber DC, Sherriff SB, Holdsworth CD. Reticuloendothelial function in coeliac disease and ulcerative colitis. Gut 1983;24:384–388.
  • Wardrop CA, Dagg JH, Lee FD, Singh H, Dyet JF, Moffat A. Immunological abnormalities in splenic atrophy. Lancet 1975;2:4–7.
  • Corazza GR, Frisoni M, Vaira D, Gasbarrini G. Effect of gluten-free diet on splenic hypofunction of adult coeliac disease. Gut 1983;24:228–230.
  • Trewby PN, Chipping PM, Palmer SJ, Roberts PD, Lewis SM, Stewart JS. Splenic atrophy in adult coeliac disease: Is it reversible? Gut 1981;22:628–632.
  • Corazza GR, Frisoni M, Vaira D, Gasbarrini G. Effect of gluten-free diet on splenic hypofunction of adult coeliac disease. Gut 1983;24:228–230.
  • O’Grady JG, Stevens FM, Harding B, O’Gorman TA, McNicholl B, McCarthy CF. Hyposplenism and gluten-sensitive enteropathy. Natural history, incidence, and relationship to diet and small bowel morphology. Gastro-enterology 1984;87:1326–1331.
  • Corazza GR, Zoli G, Di Sabatino A, Ciccocioppo R, Gasbarrini G. A reassessment of splenic hypofunction in celiac disease. Am J Gastroenterol 1999;94:391–397.
  • Corazza GR, Bullen AW, Hall R, Robinson PJ, Losowsky MS. Simple method of assessing splenic function in coeliac disease. Clin Sci (Lond) 1981;60:109–113.
  • Trewby PN, Chipping PM, Palmer SJ, Roberts PD, Lewis SM, Stewart JS. Splenic atrophy in adult coeliac disease: Is it reversible? Gut 1981;22:628–632.
  • O’Grady JG, Stevens FM, Harding B, O’Gorman TA, McNichol! B, McCarthy CF. Hyposplenism and gluten-sensitive enteropathy. Natural history, incidence, and relationship to diet and small bowel morphology. Gastro-enterology 1984;87:1326–1331.
  • Carroccio A, Giannitrapani L, Di Prima L, Iannitto E, Montalto G, Notarbartolo A. Extreme thrombocytosis as a sign of coeliac disease in the elderly: Case report. Eur J Gastroenterol Hepatol 2002;14:897–900.
  • Pettit JE, Hoffbrand AV, Seah PP, Fry L. Splenic atrophy in dermatitis herpetiformis. Br Med J 1972;2:438–440.
  • Schmitz F, Herzig KR, Stuber E, Tiemann M, Reinecke-Luthge A, Nitsche R, et al. On the pathogenesis and clinical course of mesenteric lymph node cavitation and hyposplen-ism in coeliac disease. Int J Colorectal Dis 2002;17:192–198.
  • Le Quellec A, Ciurana AJ, Greth I, Eliaou JF, Pages A. Hemorrhagic necrosis of the mesenteric lymph nodes in adult celiac disease. Physiopathologic interpretation of 1 case. Ann Pathol 1990;10: 194–197.
  • Arotcarena R, Hammel P, Terris B, Guth A, Bemades P, Ruszniewski P. Regression of mesenteric lymph node cavitation syndrome complicating celiac disease after a gluten free diet. Gastroenterol Clin Biol 2000;24:579–581.
  • Arotcarena R, Hammel P, Terris B, Guth A, Bemades P, Ruszniewski P. Regression of mesenteric lymph node cavitation syndrome complicating celiac disease after a gluten free diet. Gastroenterol Clin Biol 2000;24:579–581.
  • Robertson DA, Swinson CM, Hall R, Losowsky MS. Coeliac disease, splenic function, and malignancy. Gut 1982;23: 666–669.
  • Stevens FM, Connolly CE, Murray JP, McCarthy CF. Lung cavities in patients with coeliac disease. Digestion 1990;46: 72–80.
  • Ryan FP, Smart RC, Holdsworth CD, Preston FE. Hyposplenism in inflammatory bowel disease. Gut 1978; 19:50–55.
  • Ryan FP, Smart R, Preston FE, Holdsworth CD. Hyposplen-ism in ulcerative colitis. Lancet 1974;2:318–320.
  • Palmer KR, Sherriff SB, Holdsworth CD, Ryan FP. Further experience of hyposplenism in inflammatory bowel disease. Q J Med 1981;50:463–471.
  • Ryan FP, Smart RC, Holdsworth CD, Preston FE. Hyposplenism in inflammatory bowel disease. Gut 1978; 19:50–55.
  • Muller AF, Cornford E, Toghill PJ. Splenic function in inflammatory bowel disease: Assessment by differential interference microscopy and splenic ultrasound. Q J Med 1993;86:333–340.
  • Pereira JL, Hughes LE, Young HL. Spleen size in patients with inflammatory bowel disease. Does it have any clinical significance? Dis Colon Rectum 1987;30:403–409.
  • Muller AF, Cornford E, Toghill PJ. Splenic function in inflammatory bowel disease: Assessment by differential interference microscopy and splenic ultrasound. Q J Med 1993;86:333–340.
  • Palmer KR, Sherriff SB, Holdsworth CD, Ryan FP. Further experience of hyposplenism in inflammatory bowel disease. Q J Med 1981;50:463–471.
  • Jewell DP, Berney JJ, Pettit JE. Splenic phagocytic function in patients with inflammatory bowel disease. Pathology 1981;13:717–723.
  • Douglas AP, Weetman AP, Haggith JW. The distribution and enteric loss of 51Cr-labelled lymphocytes in normal subjects and in patients with coeliac disease and other disorders of the small intestine. Digestion 1976;14: 29–43.
  • Doe WF, Booth CC, Brown DL. Evidence for complement-binding immune complexes in adult coeliac disease, Crohn’s disease, and ulcerative colitis. Lancet 1973;1:402–403.
  • Palmer KR, Barber DC, Sherriff SB, Holdsworth CD. Reticuloendothelial function in coeliac disease and ulcerative colitis. Gut 1983;24:384–388.
  • Palmer KR, Barber DC, Sherriff SB, Holdsworth CD. Reticuloendothelial function in coeliac disease and ulcerative colitis. Gut 1983;24:384–388.
  • Di Sabatino A, Rosado MM, Ciccocioppo R, Cazzola P, Morera R, Corazza GR, et al. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am J Gastroenterol 2005;100: 1788–1795.
  • Freeman HJ. Functional asplenia and microscopic (collage-nous) colitis. Can J Gastroenterol 1996;10:443–446.
  • Muller AF, Toghill PJ. Hyposplenism in gastrointestinal disease. Gut 1995;36:165–167.
  • Suarez RM, Spies TD, Suarez RMJ. The use of folic acid in sprue. Ann Intern Med 1947;26:643–647.
  • Haeney MR, Ross IN. Whipple’s disease in a female with impaired cell-mediated immunity unresponsive to co-trimoxazole and levamisole therapy. Postgrad Med J 1978;54:45–50.
  • Foster PN, Bullen AW, Robertson DA, Chalmers DM, Losowsky MS. Development of impaired splenic function in intestinal lymphangiectasia. Gut 1985;26:861–864.
  • Mills PR, Brown IL, Watkinson G. Idiopathic chronic ulcerative enteritis. Report of five cases and review of the literature. Q J Med 1980;49:133–149.
  • Zoli G, Corazza GR, Wood S, Bartoli R, Gasbarrini G, Farthing MJ. Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition. Gut 1998;43:759–762.
  • Seidner DL, Mascioli EA, Istfan NW, Porter KA, Selleck K, Blackburn GL, et al. Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. JPEN J Parenter Enteral Nutr 1989;13:614–619.
  • Jensen GL, Mascioli EA, Seidner DL, Istfan NW, Domnitch AM, Selleck K, et al. Parenteral infusion of long- and medium-chain triglycerides and reticuloendothelial system function in man. JPEN J Parenter Enteral Nutr 1990;14:467–471.
  • Zoli G, Corazza GR, Wood S, Bartoli R, Gasbarrini G, Farthing MJ. Impaired splenic function and tuftsin deficiency in patients with intestinal failure on long term intravenous nutrition. Gut 1998;43:759–762.
  • Muller AF, Toghill PJ. Splenic function in alcoholic liver disease. Gut 1992;33:1386–1389.
  • Muller AF, Toghill PJ. Functional hyposplenism in alcoholic liver disease: A toxic effect of alcohol? Gut 1994;35: 679–682.
  • Niemela O, Klajner F, Orrego H, Vidins E, Blendis L, Israel Y. Antibodies against acetaldehyde-modified protein epitopes in human alcoholics. Hepatology 1987;7:1210–1214.
  • Lieber CS. Perspectives: Do alcohol calories count? Am J Clin Nutr 1991;54:976–982.
  • Satapathy SK, Narayan S, Varma N, Dhiman RK, Varma S, Chawla Y. Hyposplenism in alcoholic cirrhosis, facts or artifacts? A comparative analysis with non-alcoholic cirrhosis and extrahepatic portal venous obstruction. J Gastroenterol Hepatol 2001;16:1038–1043.
  • Corazza GR, Addolorato G, Biagi F, Caputo F, Castelli E, Stefanini GF, et al. Splenic function and alcohol addiction. Alcohol Clin Exp Res 1997;21:197–200.
  • Pirovino M, Lydick E, Grob PJ, Arrenbrecht S, Altorfer J, Schmid M. Pneumococcal vaccination: The response of patients with alcoholic liver cirrhosis. Hepatology 1984;4:946–949.
  • Trevisani F, Castelli E, Foschi FG, Parazza M, Loggi E, Bertelli M, et al. Impaired tuftsin activity in cirrhosis: Relationship with splenic function and clinical outcome. Gut 2002;50:707–712.
  • Dhawan VM, Spencer RP, Sziklas H. Reversible functional asplenia in chronic aggressive hepatitis. J Nucl Med 1979;20:34–36.
  • Jaffe CJ, Vierling JM, Jones EA, Lawley TJ, Frank MM. Receptor specific clearance by the reticuloendothelial system in chronic liver diseases. Demonstration of defective C3b-specific clearance in primary biliary cirrhosis. J Clin Invest 1978;62: 1069–1077.
  • Markus HS, Muller AF, Toghill PJ. Splenic function, assessed by quantification of erythrocyte membrane pits, is normal in chronic active hepatitis and primary biliary cirrhosis. J Hepatol 1993;18:106–111.
  • Dillon AM, Stein HB, English RA. Splenic atrophy in systemic lupus erythematosus. Ann Intern Med 1982;96: 40–43.
  • Neilan BA, Berney SN. Hyposplenism in systemic lupus erythematosus. J Rheumatol 1983;10:332–334.
  • Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH. Defective reticuloendothelial system Fc-receptor func-tion in systemic lupus erythematosus. N Engl J Med 1979; 300:518–523.
  • Lockwood CM, Worlledge S, Nicholas A, Cotton C, Peters DK. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 1979;300:524–530.
  • Elkon KB, Sewell JR, Ryan PF, Hughes GR. Splenic function in non-renal systemic lupus erythematosus. Am J Med 1980;69:80–82.
  • Lockwood CM, Worlledge S, Nicholas A, Cotton C, Peters DK. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 1979;300:524–530.
  • Santilli D, Govoni M, Prandini N, Rizzo N, Trotta F. Autosplenectomy and antiphospholipid antibodies in sys-temic lupus erythematosus: A pathogenetic relationship? Semin Arthritis Rheum 2003;33:125–133.
  • Pettersson T, Julkunen H. Asplenia in a patient with systemic lupus erythematosus and antiphospholipid antibodies. J Rheumatol 1992;19:1159.
  • Fields TR, Zarrabi MH, Gerardi EN, Bennett RS, Zucker S, Hamburger MI. Reticuloendothelial system Fc receptor function in the drug induced lupus erythematosus syndrome. J Rheumatol 1986;13:726–731.
  • Williams BD, Pussell BA, Lockwood CM, Cotton C. Defective reticuloendothelial system function in rheumatoid arthritis. Lancet 1979;1:1311–1314.
  • Gordon PA, Davis P, Russell AS, Coates JE, Rothwell RS, LeClercq SM. Splenic reticuloendothelial function in patients with active rheumatoid arthritis. J Rheumatol 1981;8:490–493.
  • Henderson JM, Bell DA, Harth M, Chamberlain MJ. Reticuloendothelial function in rheumatoid arthritis: Corre-lation with disease activity and circulating immune com-plexes. J Rheumatol 1981;8:486–489.
  • Gordon PA, Davis P, Russell AS, Coates JE, Rothwell RS, LeClercq SM. Splenic reticuloendothelial function in patients with active rheumatoid arthritis. J Rheumatol 1981;8:490–493.
  • Henderson JM, Bell DA, Harth M, Chamberlain MJ. Reticuloendothelial function in rheumatoid arthritis: Corre-lation with disease activity and circulating immune com-plexes. J Rheumatol 1981;8:486–489.
  • Brownlie BE, Hamer JW, Cook HB, Hamwood SM. Letter: Thyrotmdcosis associated with splenic atrophy. Lancet 1975;2:1046–1047.
  • Jellinek EH, Ball K. Letter: Hashimoto’s disease, encephalo-pathy, and splenic atrophy. Lancet 1976;1:1248.
  • Wardrop CA, Dagg JH, Lee FD, Singh H, Dyet JF, Moffat A. Immunological abnormalities in splenic atrophy. Lancet 1975;2:4–7.
  • Lockwood CM, Worlledge S, Nicholas A, Cotton C, Peters DK. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med 1979;300:524–530.
  • McGinley E, Martin W, Henderson N, Boulton-Jones JM. Defective splenic reticuloendothelial function in idiopathic membranous nephropathy. Clin Exp Immunol 1984;56: 295–301.
  • Frank MM, Lawley TJ, Hamburger MI, Brown EJ. NIH Conference: Immunoglobulin G Fc receptor-mediated clearance in autoimmune diseases. Ann Intern Med 1983; 98:206–218.
  • Winston DJ, Schiffman G, Wang DC, Feig SA, Lin CH, Marso EL, et al. Pneumococcal infections after human bone-marrow transplantation. Ann Intern Med 1979;91:835–841.
  • Atkinson K, Storb R, Prentice RL, Weiden PL, Witherspoon RP, Sullivan K, et al. Analysis of late infections in 89 long-term survivors of bone marrow transplantation. Blood 1979;53:720–731.
  • Demetrakopoulos GE, Tsokos GC, Levine AS. Recovery of splcnic function after GVHD-associated functional asplenia. Am J Hematol 1982;12:77–80.
  • Al Eid MA, Tutschka PJ, Wagner HN, Jr, Santos GW, Tsan MF. Functional asplenia in patients with chronic graft-versus-host disease: Concise communication. J Nucl Med 1983;24:1123–1126.
  • Kalhs P, Panzer S, Kletter K, Minar E, Stain-Kos M, Walter R, et al. Functional asplenia after bone marrow transplan-tation. A late complication related to extensive chronic graft-versus-host disease. Ann Intern Med 1988;109:461–464.
  • Cuthbert RJ, Iqbal A, Gates A, Toghill PJ, Russell NH. Functional hyposplenism following allogeneic bone marrow transplantation. J Clin Pathol 1995;48:257–259.
  • Picardi M, Selleri C, Rotoli B. Spleen sizing by ultrasound scan and risk of pneumococcal infection in patients with chronic GVHD: Preliminary observations. Bone Marrow Transplant 1999;24:173–177.
  • Buchanan GR, Holtkamp CA. Splenic reticuloendothelial function in children with cancer. J Pediatr 1985;106: 239–242.
  • Simoes BP, Tone LG, Zago MA, Figueiredo MS. Splenic function in acute leukemia. Acta Haematol 1995;94: 123–127.
  • Gross DJ, Braverman AJ, Koren G, Rabinowitz YS, Gordon R, Okon E. Functional asplenia in immunoblastic lym-phoma. Arch Intern Med 1982;142:2213–2215.
  • Pettit JE, Williams ED, Glass HI, Lewis SM, Szur L, Wicks CJ. Studies of splenic function in the myeloproliferative disorders and generalized malignant lymphomas. Br J Haematol 1971;20:575–586.
  • Pavlotsky F, Mekhmandarov S, Mozes B. Functional hyposplenism in a patient with advanced breast cancer. Isr J Med Sci 1989;25:589–591.
  • Costello P, Gramm HF, Steinberg D. Simultaneous occurrence of functional asplenia and splenic accumulation of diphosphonate in metastatic breast carcinoma. J Nucl Med 1977;18:1237–1238.
  • Pettit JE. Spleen function. Clin Haematol 1977;6:639–656.
  • Steinberg MH, Gatling RR, Tavassoli M. Evidence of hyposplenism in the presence of splenomegaly. Scand J Haematol 1983;31:437–439.
  • Yucel AE, Durak H, Bernay I, Bayraktar Y, Bekdik C, Telatar H. Functional asplenia and portal hypertension in a patient with primary splenic hemangiosarcoma. Clin Nucl Med 1990;15:324–326.
  • Budke HL, Breitfeld PP, Neiman RS. Functional hyposplen-ism due to a primary epithelioid hemangioendothelioma of the spleen. Arch Pathol Lab Med 1995;119:755–757.
  • Pichler WJ, Peter HH, Anagnou J, Kaup FJ, Drommer W. Sezary syndrome with hyposplenism. Blut 1984;49:75–82.
  • Marsh GW, Lewis SM, Szur L. The use of 51Cr-labelled heat-damaged red cells to study splenic function. II. Splenic atrophy in thrombocythaemia. Br J Haematol 1966;12: 167–171.
  • Roth J, Brudler O, Henze E. Functional asplenia in malignant mastocytosis. J Nucl Med 1985;26:1149–1152.
  • Ozkaynak MF, Ortega JA, Miller J. Concurrence of transient asplenia and pure red cell aplasia. Eur J Pediatr 1990;149: 542–544.
  • Garriga S, Crosby WH. The incidence of leukemia in families of patients with hypoplasia of the marrow. Blood 1959;14:1008–1014.
  • Spencer RP, Johnson PM, Sziklas JJ. Unusual scan presentation of splenic vasculature occlusion by tumor. Clin Nucl Med 1977;2:197–199.
  • Hirano T, Tomiyoshi K, Take H, Watanabe N, Oriuchi N, Inoue T, et al. Reversible functional asplenia. Autoimmune hemolytic anemia with thrombocytopenia in chronic lym-phocytic leukemia. Clin Nucl Med 1994;19:693–695.
  • Dailey MO, Coleman CN, Kaplan HS. Radiation-induced splenic atrophy in patients with Hodgkin’s disease and non-Hodgkin’s lymphomas. N Engl J Med 1980;302:215–217.
  • Coleman CN, McDougall IR, Dailey MO, Ager P, Bush S, Kaplan HS. Functional hyposplenia after splenic irradiation for Hodgkin’s disease. Ann Intern Med 1982;96:44–47.
  • Coleman CN, McDougall IR, Dailey MO, Ager P, Bush S, Kaplan HS. Functional hyposplenia after splenic irradiation for Hodgkin’s disease. Ann Intern Med 198296:44–47.
  • Grotto HZ, Costa FF. Hyposplenism in AIDS. AIDS 1991;5:1538–1540.
  • Ong KR, Stavropoulos C, Inada Y. Babesiosis, asplenia, and AIDS. Lancet 1990;336:112.
  • Khan AM, Harrington RD, Nadel M, Greenberg BR. Hyposplenism from Mycobacterium avium complex infection in a patient with AIDS and immune thrombocytopenia. Acta Haematol 1998;99:45–48.
  • Eshel Y, Sarova-Pinhas I, Lamp! Y, Jedwab M. Autosple-nectomy complicating pneumococcal meningitis in an adult. Arch Intern Med 1991151:998–999.
  • Markus HS, Toghill PJ. Impaired splenic function in elderly people. Age Ageing 1991;20:287–290.
  • Zago MA. The evaluation of spleen function in man. Braz J Med Biol Res 198922:159–169.
  • Ravaglia G, Forti P, Biagi F, Maioli F, Boschi F, Corazza GR. Splenic function in old age. Gerontology 1998;44:91–94.
  • Gertz MA, Kyle RA, Greipp PR. Hyposplenism in primary systemic amyloidosis. Ann Intern Med 1983;98:475–477.
  • Guyton JR, Zumwalt RE. Letter: Pneumococcemia with sarcoid-infiltrated spleen. Ann Intern Med 1975;82: 847–848.
  • Dhawan VM, Spencer RP, Pearson HA. Functional asplenia in the absence of circulating Howell-Jolly bodies. Clin Nucl Med 1977;2:395–396.
  • Ramsahoye BH, Evely R, Mumar-Bashi W, Lim SH. Selective IgA deficiency and hyposplenism. Clin Lab Haematol 1994;16:375–377.
  • Foster PN, Losowsky MS. Hyposplenism—a review. J R Coll Physicians Lond 1987;21:188–191.
  • Fahy G, Robinson K, Deb B, Graham I. Primary pulmonary hypertension and functional hyposplenism. Postgrad Med J 1992;68:383–385.
  • Kelton JG. Impaired reticuloendothelial function in patients treated with methyldopa. N Engl J Med 1985;313:596–600.
  • Dekker PT, Propp RP. Functional asplenia in idiopathic thrombocytopenic purpura. N Y State J Med 1977;77: 2282–2285.
  • Johnson SA, Bateman CJ, Beard ME, Whitehouse JM, Waters AH. Long-term haematological complications of thorotrast. Q J Med 1977;46:259–271.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.